Logo image of COV.PA

COVIVIO (COV.PA) Stock Analyst Earnings Estimates

EPA:COV - Euronext Paris - Matif - FR0000064578 - REIT - Currency: EUR

51.45  +0.05 (+0.1%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
COV.PA revenue by date.COV.PA revenue by date.
1.004B
2.02%
1.175B
16.94%
863.5M
-26.49%
667.71M
-22.67%
693.8M
3.91%
716.98M
3.34%
N/A
EBITDA
YoY % growth
COV.PA ebitda by date.COV.PA ebitda by date.
734.75M
2.54%
831.823M
13.21%
860.556M
3.45%
578.47M
-32.78%
607.12M
4.95%
637.01M
4.92%
671.47M
5.41%
EBIT
YoY % growth
COV.PA ebit by date.COV.PA ebit by date.
642.533M
3.53%
769.551M
19.77%
791M
2.79%
563.9M
-28.71%
653.71M
15.93%
691.83M
5.83%
N/A
Operating Margin
COV.PA operating margin by date.COV.PA operating margin by date.
63.97%65.52%91.60%84.45%94.22%96.49%N/A
EPS
YoY % growth
COV.PA eps by date.COV.PA eps by date.
4.35
3.33%
4.58
5.29%
4.47
-2.40%
4.40
-1.54%
4.44
0.91%
4.56
2.60%
4.49
-1.39%

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q2 / 25 Q4 / 25
EPS
Q2Q % growth
2.21
4.83%
2.42
8.21%
2.31
4.57%
Revenue
Q2Q % growth
616.08M
40.88%
N/AN/A
EBITDA
Q2Q % growth
N/AN/AN/A
EBIT
Q2Q % growth
457.57M
14.74%
468.09M
17.02%
475.83M
3.99%

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
2.24
-5.08%
2.220.020.81%
Q4 2023
Q2Q % growth
2.11
-4.52%
2.030.083.94%
Q2 2023
Q2Q % growth
2.36
-0.42%
2.330.031.15%
Q4 2022
Q2Q % growth
2.21
2.31%
2.24-0.03-1.44%
Q2 2022
Q2Q % growth
2.37
8.22%
2.280.093.83%
Q4 2021
Q2Q % growth
2.16
5.88%
2.28-0.12-5.37%
Q2 2021
Q2Q % growth
2.19
0.92%
2.030.167.88%
Q4 2020
Q2Q % growth
2.04
-23.88%
2.32-0.28-12.18%
Q2 2020
Q2Q % growth
2.17
-17.49%
2.48-0.31-12.66%
Q4 2019
Q2Q % growth
2.68 3.08-0.40-13.00%
Q2 2019
Q2Q % growth
2.63 3.09-0.46-14.90%
COV.PA Yearly EPS VS EstimatesCOV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
431.3M
1.20%
287.85M143.45M49.83%
Q4 2023
Q2Q % growth
437.3M
-29.85%
%
Q2 2023
Q2Q % growth
426.2M
-22.68%
%
Q4 2022
Q2Q % growth
623.385M
14.33%
%
Q2 2022
Q2Q % growth
551.215M
20.04%
%
Q4 2021
Q2Q % growth
545.268M
12.01%
%
Q2 2021
Q2Q % growth
459.194M
-7.76%
%
Q4 2020
Q2Q % growth
486.786M
-21.16%
%
Q2 2020
Q2Q % growth
497.831M
-18.41%
%
COV.PA Yearly Revenue VS EstimatesCOV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0.14% 0.14%
RevenueN/A N/A 0.51% -0.13%